Compare ZDAI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZDAI | IMCC |
|---|---|---|
| Founded | 2022 | 1980 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | General Bldg Contractors - Nonresidential Bldgs | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 7.2M |
| IPO Year | 2024 | N/A |
| Metric | ZDAI | IMCC |
|---|---|---|
| Price | $0.58 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 307.3K | 69.3K |
| Earning Date | 02-03-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,141,479.00 | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $0.20 | $0.93 |
| 52 Week High | $1.17 | $7.12 |
| Indicator | ZDAI | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 45.82 |
| Support Level | $0.42 | $1.28 |
| Resistance Level | $0.65 | $1.48 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 81.55 | 41.08 |
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.